Table.
Patient data
| Medications |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Diagnosis | Dominant Ventricle | Ross Score | Age (mo) | Wt (kg) | Sex | Surgical Palliation* | Diuretics | Angiotensin converting enzyme inhibitor | Digoxin | Intravenous inotropic agents |
| Heart Failure (Ross Score ≥3) | ||||||||||
| Aortic and mitral atresia | Right | 6 | 5 | 6.3 | M | Stage I | X | X | ||
| Aortic and mitral atresia | Right | 3 | 6 | 5.6 | M | Stage I | X | X | ||
| Aortic and mitral atresia | Right | 9 | 24 | 11.0 | M | Stage II | X | X | X | X |
| Double outlet right ventricle | Right | 4 | 73 | 15.7 | M | Stage II | X | X | ||
| Unbalanced atrioventricular canal | Right | 3 | 6 | 5.3 | M | Stage II | ||||
| Unbalanced atrioventricular canal | Right | 8 | 42 | 17.0 | M | Stage II | X | X | X | X |
| Double inlet left ventricle | Left | 3 | 24 | 9.5 | M | Stage II | X | |||
| Double inlet left ventricle | Left | 6 | 54 | 12.4 | M | Stage II | X | |||
| Primitive ventricle | Indeterminate | 4 | 16 | 8.7 | M | Stage II | X | X | X | |
| No Heart Failure (Ross Score ≤2) | ||||||||||
| Aortic and mitral atresia | Right | 0 | 4 | 5.0 | M | Stage I | X | |||
| Aortic and mitral atresia | Right | 0 | 71 | 16.7 | M | Stage III | X | |||
| Aortic and mitral stenosis | Right | 1 | 4 | 6.0 | M | Stage I | X | |||
| Aortic and mitral stenosis | Right | 1 | 4 | 6.1 | M | Stage I | X | |||
| Aortic and mitral stenosis | Right | 1 | 4 | 5.6 | F | Stage I | X | X | ||
| Aortic and mitral stenosis | Right | 2 | 42 | 13.6 | M | Stage II | X | X | X | |
| Interrupted aortic arch | Right | 2 | 4 | 5.2 | F | Stage I | X | X | ||
| Double outlet right ventricle | Right | 1 | 29 | 19.0 | F | Stage II | ||||
| Interrupted aortic arch | Right | 2 | 4 | 5.2 | F | Stage I | X | X | ||
| Unbalanced atrioventricular canal | Right | 1 | 60 | 17.0 | M | Stage II | X | X | ||
| Unbalanced atrioventricular canal | Right | 2 | 5 | 5.2 | F | Stage I | X | X | X | |
| Unbalanced atrioventricular canal | Right | 2 | 40 | 15.4 | M | Stage II | ||||
| Interrupted aortic arch | Left | 2 | 5 | 5.7 | F | Stage I | X | X | ||
| Pulmonary atresia/intact ventricular septum | Left | 2 | 69 | 16.0 | M | Stage II | ||||
| Pulmonary atresia/ventricular septal defect | Left | 1 | 54 | 15.0 | M | Stage II | X | |||
| Tricuspid atresia | Left | 0 | 3 | 5.0 | M | Stage I | X | |||
| Tricuspid atresia | Left | 0 | 4 | 5.3 | F | Stage I | X | |||
| Tricuspid atresia | Left | 0 | 6 | 7.7 | M | Stage II | X | |||
| Tricuspid atresia | Left | 2 | 42 | 19.4 | F | Stage II | X | |||
| Primitive ventricle | Indeterminate | 2 | 66 | 17.0 | M | Stage II | X | X | ||
*
Stage I: stabilization of aortic and pulmonary blood flow, e.g., Norwood, pulmonary artery band, Blalock-Taussig shunt, central shunt; Stage II: establishment of partial cavopulmonary circulation between the superior vena cava and pulmonary arteries, e.g., Glenn shunt, Kawashima; Stage III: completion of cavopulmonary circulation, e.g., Fontan.